Home > Cashflow Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Cashflow Statement

KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹39 Cr₹34 Cr₹19 Cr₹12 Cr₹9.61 Cr
Adjustment ₹7.95 Cr₹1.16 Cr₹10 Cr₹9.79 Cr₹3.89 Cr
Changes In working Capital ₹-12 Cr₹-9.63 Cr₹-24 Cr₹-15 Cr₹-5.19 Cr
Cash Flow after changes in Working Capital ₹34 Cr₹26 Cr₹5.50 Cr₹6.92 Cr₹8.32 Cr
Cash Flow from Operating Activities ₹24 Cr₹18 Cr₹-1.53 Cr₹2.59 Cr₹5.78 Cr
Cash Flow from Investing Activities ₹-100 Cr₹-40 Cr₹-8.16 Cr₹7.92 Cr₹-15 Cr
Cash Flow from Financing Activities ₹82 Cr₹13 Cr₹8.81 Cr₹-0.72 Cr₹7.03 Cr
Net Cash Inflow / Outflow ₹5.97 Cr₹-9.16 Cr₹-0.88 Cr₹9.78 Cr₹-2.44 Cr
Opening Cash & Cash Equivalents ₹9.80 Cr₹19 Cr₹20 Cr₹10 Cr₹13 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹16 Cr₹9.80 Cr₹19 Cr₹20 Cr₹10 Cr

Compare Cashflow Statement of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹699.8 Cr -5.4% -21.3% -0.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,589.0 Cr 1.4% 8.1% -6.8% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-5.4%

-21.3%

-0.4%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses